文献速递其他结缔组织病

原发性干燥综合征的变异性由干扰素-α驱动,且干扰素-α血液水平与II类HLA-DQ位点相关

Variability of Primary Sjögren's Syndrome Is Driven by Interferon-α and Interferon-α Blood Levels Are Associated With the Class II HLA-DQ Locus.
PubMed 文献 · Arthritis Rheumatol · 2022-11-02

在351例原发性干燥综合征患者的多中心前瞻性临床队列中,整合转录组、蛋白质组、细胞和遗传数据与临床表型,并在3个独立队列(n=462)中重复转录组分析。转录组显示超过半数患者存在强干扰素基因特征,由循环干扰素-α而非干扰素-γ驱动;干扰素-α蛋白水平在75%患者中可检测到,与入组时疾病活动临床免疫特征及5年随访期间系统性并发症频率增加显著相关,并与MHC II类单倍型及抗SSA抗体相关。

要点

  • 超过半数原发性干燥综合征患者存在强干扰素基因特征,并在3个独立队列中重复。
  • 干扰素转录组特征由循环干扰素-α而非干扰素-γ蛋白水平驱动。
  • 干扰素-α蛋白水平与入组时疾病活动及5年随访系统性并发症增加显著相关。

核心结论

  • 原发性干燥综合征以干扰素-α占优势为其变异性驱动因素,且干扰素-α与HLA基因多态性相关。

研究设计与样本

  • 多中心前瞻性临床队列纳入351例原发性干燥综合征患者,分析血液转录组和基因型,并在3个独立队列(n=462例患者)中重复转录组分析。
  • 采用数字单分子阵列(Simoa)测定循环干扰素-α和干扰素-γ蛋白浓度。

主要发现

  • 前瞻性队列转录组分析显示超过半数患者存在强干扰素基因特征,该发现在3个独立队列中重复。
  • Simoa显示干扰素转录组特征由循环干扰素-α而非干扰素-γ蛋白水平驱动。
  • 干扰素-α蛋白水平在75%患者中可检测到,与入组时原发性干燥综合征疾病活动的临床和免疫学特征显著相关,并与5年随访期间系统性并发症频率增加显著相关。
  • 遗传分析显示干扰素-α蛋白水平、主要组织相容性复合体(MHC)II类单倍型与抗SSA抗体之间存在显著关联。
  • 细胞分析显示MHC II类HLA-DQ位点通过上调常规树突状细胞上的HLA II类分子发挥作用。

关键数值与推荐

  • 原发性干燥综合征影响普通人群的0.1%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Primary Sjögren's syndrome (SS) is the second most frequent systemic autoimmune disease, affecting 0.1% of the general population. To characterize the molecular and clinical variabilities among patients with primary SS, we integrated transcriptomic, proteomic, cellular, and genetic data with clinical phenotypes in a cohort of 351 patients with primary SS. METHODS: We analyzed blood transcriptomes and genotypes of 351 patients with primary SS who were participants in a multicenter prospective clinical cohort. We replicated the transcriptome analysis in 3 independent cohorts (n = 462 patients). We determined circulating interferon-α (IFNα) and IFNγ protein concentrations using digital single molecular arrays (Simoa). RESULTS: Transcriptome analysis of the prospective cohort showed a strong IFN gene signature in more than half of the patients; this finding was replicated in the 3 independent cohorts. Because gene expression analysis did not discriminate between type I IFN and type II IFN, we used Simoa to demonstrate that the IFN transcriptomic signature was driven by circulating IFNα and not by IFNγ protein levels. IFNα protein levels, detectable in 75% of patients, were significantly associated with clinical and immunologic features of primary SS disease activity at enrollment and with increased frequency of systemic complications over the 5-year follow-up. Genetic analysis revealed a significant association between IFNα protein levels, a major histocompatibility (MHC) class II haplotype, and anti-SSA antibody. Additional cellular analysis revealed that an MHC class II HLA-DQ locus acts through up-regulation of HLA class II molecules on conventional dendritic cells. CONCLUSION: We identified the predominance of IFNα as a driver of primary SS variability, with IFNα demonstrating an association with HLA gene polymorphisms.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Trutschel D, Bost P, Mariette X, et al. Variability of Primary Sjögren's Syndrome Is Driven by Interferon-α and Interferon-α Blood Levels Are Associated With the Class II HLA-DQ Locus. Arthritis Rheumatol. 2022. PMID: 35726083. doi:10.1002/art.42265

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。